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Neural development is a complex process that involves critical events, including
cytoskeleton dynamics and selective trafficking of proteins to defined cellular
destinations. In this regard, Smad Anchor for Receptor Activation (SARA) is an
early endosome resident protein, where perform trafficking- associated functions. In
addition, SARA is also involved in cell signaling, including the TGFβ-dependent pathway.
Accordingly, SARA, and TGFβ signaling are required for proper axonal specification
and migration of cortical neurons, unveiling a critical role for neuronal development.
However, the cooperative action between the TGFβ pathway and SARA to this process
has remained understudied. In this work, we show novel evidence suggesting a
cross-talk between SARA and TGFβ pathway needed for proper polarization, axonal
specification, growth and cortical migration of central neurons both in vitro and
in vivo. Using microscopy tools and cultured hippocampal neurons, we show a local
interaction between SARA and TβRI (TGFβ I receptor) at endosomes. In addition,
SARA loss of function, induced by the expression of the dominant-negative SARA-
F728A, over-activates the TGFβ pathway, most likely by preserving phosphorylated
TβRI. Consequently, SARA-mediated activation of TGFβ pathway impacts on neuronal
development, promoting axonal growth and cortical migration of neurons during brain
development. Moreover, our data suggests that SARA basally prevents the activation
of TβRI through the recruitment of the inhibitory complex PP1c/GADD34 in polarizing
neurons. Together, these results propose that SARA is a negative regulator of the TGFβ
pathway, being critical for a proper orchestration for neuronal development.
Keywords: TGFβ, Smad Anchor for Receptor Activation (SARA), neurons, development, axon, migration,
endosomes
INTRODUCTION
The neuronal development is a complex process that begins early at the embryonic life.
After differentiation, post-mitotic neurons undergo progressive morphological transformations
to specify their somato-dendritic and axonal compartments; a process called “the establishment
of polarity” (Dotti et al., 1988; Cid-Arregui et al., 1995; Caceres et al., 2012). Therefore, the
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coordination of several events are needed, including the
selective transport of polarity determinants by the endosomal
trafficking machinery (Sann et al., 2009; Falk et al., 2014;
Takano et al., 2014; Mestres et al., 2016), local segregation of
proteins in axon and dendrites (Chuang et al., 2005; Arimura
and Kaibuchi, 2007; Funahashi et al., 2020) and a highly
dynamic cytoskeleton of microtubules and actin microfilaments
(Conde and Caceres, 2009; Wilson et al., 2015). Accordingly,
several small GTPase proteins belonging to the Rab (Ras-
associated binding) family, controlling intracellular transport,
contribute to neuronal polarization (Villarroel-Campos et al.,
2016); nevertheless, additional partners are needed. In this
regard, Smad Anchor for Receptor Activation (SARA), an
early endosome (EE) binding protein, regulates endosomal
trafficking and axonal growth of neurons (Tsukazaki et al.,
1998; Arias et al., 2015; Mestres et al., 2016). Although
the suppression of SARA impairs endosomal dynamics
and neuronal development (Arias et al., 2015; Mestres
et al., 2016), the mechanistic aspects underlying this effect
are still missing.
At endosomes, SARA performs several trafficking functions,
including sorting and recycling of membrane proteins such as
the Transferrin receptor (TfR) and Rhodopsin (Hu et al., 2002;
Chuang et al., 2007; Arias et al., 2015), endosomal segregation
during cell division (Coumailleau et al., 2009; Kressmann
et al., 2015) and distribution to intracellular compartments
(Arias et al., 2015).
However, non-trafficking roles of SARA have also emerged.
In fact, SARA participates in cell signaling regulation, including
the Notch/Delta pathway in sensory organs of D. melanogaster
(Coumailleau et al., 2009; Loubery et al., 2014) and both the
Epidermal Growth Factor (EGF) and the Transforming Growth
Factor (TGFβ)-dependent pathway in epithelial cells, among
others (Tsukazaki et al., 1998; Wu et al., 2000; Kostaras et al.,
2013, 2014; Rozes-Salvador et al., 2018). Accordingly, TGFβ
signaling demands a precise coordination between ligands,
receptors, regulatory proteins and transcriptional factors to
control proliferation, differentiation, metabolism and apoptosis
(Wrana et al., 1994; Shi and Massague, 2003; Wharton and
Derynck, 2009; Akhurst and Hata, 2012; David and Massague,
2018). For this aim, SARA recruits Smad2 and Smad3 to the
TGFβ type I receptor (TβRI), enabling their phosphorylation
and nuclear translocation for transcriptional control (Wrana
et al., 1994; Tsukazaki et al., 1998; Panopoulou et al., 2002;
Tang et al., 2015). However, SARA is also able to down-
regulate this pathway. In both primary cultures of epithelial
cells and cell lines, SARA binds to PP1c (the catalytic unit
of protein phosphatase 1), which in turns assembles with
Smad7 and GADD34; a complex able to dephosphorylate - and
inactivate –TβRI (Attisano and Wrana, 2002; Shi et al., 2004;
Tang et al., 2010). Therefore, a dual role for SARA has been
described, although its precise regulation and impact on neuronal
development remain unexplored.
TGFβ plays central roles for the physiology of the nervous
system, including inflammatory response modulation,
neural commitment, development and progression of
several neurodegenerative diseases (van der Wal et al., 1993;
Mogi et al., 1995; Vogel et al., 2010; Yi et al., 2010;
Meyers and Kessler, 2017). Accordingly, TGFβ also promotes
neuronal polarity acquisition and corticogenesis, being critical for
brain and neuronal development (Yi et al., 2010). Nevertheless,
the regulation of TGFβ signaling by SARA during this process
has been understudied.
Based on in vitro and in vivo assays, we show in this work
that SARA allows polarization, axonal growth, and migration
of cortical neurons by modulating the TGFβ signaling, a
phenomenon mediated by the recruitment of the inactivating
complex PP1c/GADD34. Our data suggests that SARA is an
endogenous regulator able to fine-tune the TGFβ pathway for a
proper neuronal development in time and space.
RESULTS
Expression and Interaction of SARA and
TβRI in Polarizing Neurons
Previous reports have described the interaction between SARA
and TβRI in non-neuronal models (Tsukazaki et al., 1998;
Itoh et al., 2002); thus, we explored whether such interaction
was also reproduced in neurons. To this end, we first
measured endogenous levels of SARA and TβRI in cultured
hippocampal neurons at 1, 2, and 3 days in vitro (DIV) by
immunofluorescence (IF), a time-frame in which polarization
takes place. Figure 1A displays representative IF of SARA and
TβRI, showing that both proteins peak at 2 DIV (Figures 1B,C,
Fire-LUTs are shown to clearly visualize fluorescence levels of
each epitope). Previously, two isoforms of SARA have been
described; SARA1, a high molecular weight isoform representing
the full-length version, and SARA2, a low molecular weight
isoform lacking the Smad Binding Domain (SBD) (Chang et al.,
2014). To clarify which isoform is expressed in polarizing
neurons, we analyzed their expression in protein homogenates
isolated from 1 to 3 DIV hippocampal neurons. We found
that SARA1 is the main variant expressed and, consistently
with our IF analysis, it increases the expression at 2 DIV
(Figures 1D–E). Also, the dynamics of the expression of SARA1
and SARA2 shows that SARA1 peaks at 2DIV compared to
SARA2 (Figure 1F).
Then we explored the interaction between SARA and TβRI.
Considering that SARA is an EE protein, we decided to analyze
local interactions in EEs at neuronal soma by using Acceptor
Photobleaching Förster Resonance Energy Transfer (AP-FRET).
Therefore, hippocampal neurons were transiently transfected
with plasmids encoding SARA-WT-GFP or shRNA-SARA-GFP,
to knock-down SARA; an empty plasmid encoding only GFP
was used as control. After 2 DIV, neurons were fixed and
immunostained for TβRI detection (Figure 1G, red channel) to
measure local FRET efficiency at EEs after bleaching the acceptor
channel (red channel) (Figure 1G). Neurons expressing SARA-
WT-GFP displayed higher FRET efficiency than controls after
bleaching (Figures 1G,H, see Donor Fire-LUT), reporting an
interaction between SARA and TβRI in developing neurons. On
one hand, these results confirm that both SARA and TβRI are
expressed within the time-frame of neuronal polarization; on the
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FIGURE 1 | SARA controls TGFβ pathway activation in developing hippocampal neurons. (A) Representative images showing immunofluorescence (IF) detection of
endogenous levels of SARA (green), TβRI (red) in cultured hippocampal neurons of 1, 2, and 3 DIV. Fire-LUTs are shown to clearly visualize IF levels. (B,C)
Quantification of fluorescence intensity of SARA (B) and TβRI (C). A total of 80 neurons were analyzed for each condition. *p < 0.05, **p < 0.005, ***p < 0.001,
ANOVA, Dunnett’s post-test. (D) Representative detection of SARA protein levels by Western blot; protein homogenates were isolated from cultured hippocampal
neurons of 1–3 DIV. (E) Western blotting quantification of the SARA1 and SARA2 expression normalized with the load control (β-actin). (F) Representation of the
dynamics changes of the expression of SARA1 and SARA2 in cultured hippocampal neurons of 1–3 DIV. (G) Representative images showing transfected neurons
with GFP or SARA-WT-GFP (green channel, donor) and immunostained for TβRI (red channel, acceptor: Alexa Fluor 546) for Acceptor Photobleaching (AP)-FRET
analysis. Briefly, neurons were transfected after plating and fixed at two DIV for FRET imaging. Squares show the region bleached in the soma (magnification of these
regions are shown as insets). Arrows show local interaction between SARA and TβRI at endosomes. (H) Quantification of FRET efficiency in control (GFP) and
SARA-WT-GFP neurons at 2 DIV. **p < 0.005, ***p < 0.001 vs control (white column), ns: non-significant, ANOVA, Dunnett’s post-test (15 neurons were analyzed by
condition). (I) Representative images of hippocampal neurons transfected with GFP, SARA-WT-GFP, shRNA-SARA, or SARA-F728A-GFP and immunostained to
detect phospho-Smad2/3 (red channel), total Smad2/3 (gray channel), and DAPI levels (cyan channel). Neurons were transfected after plating and fixed at 2 DIV for
IF staining. (J) Quantification of nuclear phospho/total Smad2/3 IF signal after TGFβ treatment (2 ng/ml) for 0, 30, 60, 120 min in 2 DIV neurons. *p < 0.05 vs control,
Kruskal–Wallis test, (20 neurons were analyzed by condition). Results represent the mean of three independent neuronal cultures (n = 3). Scale bar: 20 µm; FRET
Scale bar: 5 µm.
other, this data also suggests a local interaction between SARA
and TβRI at EEs.
The Loss of Function of SARA Leads to
TGFβ Pathway Over-Activation in
Developing Neurons
Previous reports in primary cultures of epithelial cells and cell
lines showed that the ectopic expression of SARA-F728A,
a mutant with dominant negative effect, induces TβRI
hyperphosphorylation through a PP1c-dependent mechanism
(Bennett and Alphey, 2002; Shi et al., 2004). Therefore, we
explored the consequence of blocking SARA on the activation
of TGFβ pathway in hippocampal neurons. As a readout of
TβRI activation, we analyzed the nuclear translocation of
Smad2/3 in control and SARA-inhibited neurons. For this,
neurons were transfected immediately after plating with
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plasmids encoding GFP, SARA-WT-GFP, shRNA-SARA-GFP,
or SARA-F728A-GFP. After 24 h of transfection, neurons were
treated with TGFβ1 (2 ng/ml) for 0, 30, 60, and 120 min.
Then, neurons were fixed and immunostained by IF to detect
total and phosphorylated Smad2/3 levels (Figure 1I). We
found that neurons expressing either shRNA-SARA-GFP or
SARA F728A-GFP reached a peak of [phospho-Smad2/3 /
total Smad2/3] nuclear fluorescence after 30 min of TGFβ1
stimulation (Figure 1J), to then decay to resting levels. However,
in neurons expressing SARA-WT, and treated with TGFβ1, most
of Smad2/3 remained in the cytoplasm and thereby changes in
nuclear pSmad2/3 under these experimental conditions were
not significant. These results suggest that over-expression of
SARA-WT blocks the activation of TβRI by TGFβ1 supporting
the notion that SARA is basally inhibiting the TGFβ pathway in
developing neurons.
Previous reports in D. melanogaster showed that the
expression of the dominant negative SARA-F728 inhibits
TβRI dephosphorylation through a mechanism involving the
formation of a PP1c-GADD34-Smad7 complex; therefore,
endogenous SARA could be working as a membrane anchor
protein to recruit PP1c, which induces TβRI dephosphorylation
through a negative feedback mechanism (Shi et al., 2004).
Considering this evidence, we explored whether SARA interacts
with PP1c and GADD34 by AP-FRET in cultured hippocampal
neurons. For this, neurons were transfected with GFP, SARA-
WT-GFP or SARA-F728A-GFP immediately after plating and
fixed at 2 DIV, followed by immunostaining by IF to detect
endogenous PP1c (Figure 2A, red channel) or GADD34
(Figure 2C, red channel). Then, we quantified the FRET
efficiency after bleaching the acceptor (red channel) in EEs
located at soma for PP1c and GADD34 proteins (Figures 2B,D,
respectively). As expected, FRET efficiency was higher in
neurons expressing SARA-WT-GFP than controls, most likely
because SARA has a binding domain for PP1c, allowing their
interaction. Nevertheless, such interaction was significantly
enhanced in neurons expressing the mutant SARA-F728A-GFP
(Figure 2B). A similar result was obtained after analyzing
the interaction between SARA and GADD34 (Figure 2D),
suggesting that the SARA-F728A mutation increases the
local recruitment of PP1c-GADD34, which could prevent
TβRI dephosphorylation at EEs. Together, our data proposes
that SARA inactivates TGFβ pathway by enhancing PP1c-
GADD34 complex availability to dephosphorylate TβRI during
neuronal polarization.
Contribution of SARA to
TGFβ-Dependent Polarization and
Axonal Growth of Neurons in Culture
We next explored a functional relationship between
TGFβ-mediated signaling and SARA during the first
stages of polarity acquisition. Accordingly, neurons were
transfected immediately after plating with plasmids encoding
GFP, SARA-WT-GFP or SARA-F728A-GFP and then cells
were fixed and immunostained by IF to detect MAP2
and Tau-1 epitopes at 3DIV (somato-dendritic and axonal
markers, respectively) (Figure 3A). We found that neurons
expressing SARA-WT-GFP showed reduced axonal growth
and loss of Tau-1 distal gradient, indicating failures on
axonal identity acquisition. In contrast, neurons expressing
SARA-F728A-GFP showed more than one axon (defined by
Tau-1 immunoreactivity, Figures 3B,C and Supplementary
Figure 1). In addition, those neurons expressing SARA-
F728A-GFP also exhibited longer axons, without affecting
minor neurites length (Figures 3D,E), suggesting an
axon-specific effect.
Then, we evaluated whether the dominant negative
SARA-F728A was able to enhance the axonal growth in
TβRI-inhibited neurons. Accordingly, neurons were transfected
after plating with plasmids encoding GFP, SARA-WT-GFP
or SARA-F728A-GFP and then, after 24 h of culture, were
treated with either TGFβ1 or SB431542 (a pharmacological
inhibitor of TβRI, Figure 3F and Supplementary Figure 2).
As expected, the treatment with TGFβ1 increased axonal
growth in control and SARA-F728A-GFP conditions; in
contrast, the opposed effect was observed in SARA-WT-GFP
neurons (Figures 3G,H); nevertheless, SB431542 blocked the
axonal growth observed after expressing SARA-F728A-GFP
(Figures 3G–I). Together, these results suggest that SARA is an
endogenous inhibitor of TGFβ pathway during the first stages of
neuronal polarization.
The Over-Activation of the TGFβ Pathway
Alters Both the Polarity Acquisition and
Cortical Migration of Neurons in vivo
Overall, our results support the hypothesis that SARA regulates
TGFβ pathway during the acquisition of neuronal polarity, most
likely by local recruitment of PP1c/GADD34 at EEs, affecting
both polarization and axonal growth in vitro. Therefore, we
wondered whether the SARA blockade in vivo would also
affect the development of neurons. For this, we addressed in
utero electroporation (IUE) experiments in embryonic (E15)
mouse brains to express the following cDNA combinations:
pCAG-GFP (control), pCAG-GFP + SARA-WT-GFP or pCAG-
GFP + SARA-F728A-GFP. Three days after IUE (E18), we
analyzed migration of cortical neurons and their morphological
features (Figures 4A–D). Figure 4A shows representative images
of coronal slices of cortices expressing pCAG-GFP, pCAG-
GFP + SARA-WT-GFP and pCAG-GFP + SARA-F728A-GFP.
We found that brain cortices expressing pCAG-GFP + SARA-
F728A-GFP showed an increase in the number of cells reaching
the upper zones of the cortex (IZ-CP) (compared to controls).
In contrast, most of cells expressing pCAG-GFP + SARA-WT-
GFP were retained at lower layers (VZ-SVZ), being unable to
reach the IZ/CP within the time-frame analyzed (Figures 4A–C).
Therefore, we analyzed cell morphology (multipolar or bipolar)
at SVZ-IZ layers of electroporated brains (Figures 4B–D).
Notably, brains expressing pCAG-GFP + SARA-F728A-GFP
showed an increase in the number of bipolar phenotype (bipolar:
57%; multipolar 43%) compared to the control condition
(pCAG-GFP; bipolar: 36%; multipolar: 64%, Figure 4D). Of
note, most of cells expressing pCAG-GFP + SARA-WT-GFP
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FIGURE 2 | Local recruitment of PP1c and GADD34 by SARA at endosomes in developing hippocampal neurons. Neurons were transfected with GFP,
SARA-WT-GFP, or SARA-F728A-GFP after plating and fixed at 2 DIV to analyze the interaction between SARA and PP1c and GADD34 at EEs by Acceptor
Photobleaching-FRET. (A,C) Representative images of neurons transfected with GFP, SARA-WT-GFP, or SARA-F728A-GFP (green channel, donor) and
immunostained for PP1c (red cannel, acceptor, A) or GADD34 (red channel, acceptor, C). Rectangles show the region bleached in the soma (magnification of these
regions are shown as insets). Arrows show local interaction between SARA and TβRI at endosome. (B,D) Quantification of FRET efficiency for PP1c (B) and
GADD34 (D). *p < 0.05, **p < 0.005, ***p < 0.001 vs control (white column), ns: non-significant, ANOVA, Dunnett’s post-test (15 neurons were analyzed by
condition). Results represent the mean of three independent cultures (n = 3). Scale bar: 20 µm; FRET Scale bar: 5 µm.
showed a multipolar morphology (76%), a phenomenon linked
with the failure on cortical radial migration exhibited by
these neurons after expressing SARA-WT-GFP (Figures 4B–D).
Together, these results suggest that over-activation of TGFβ
pathway, achieved by the SARA blockade, accelerates the
morphological transition from multipolar to bipolar neurons,
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FIGURE 3 | Contribution of SARA to TGFβ-dependent axonal growth during neuronal development. (A) Representative images of cultured hippocampal neurons
transfected with GFP, SARA-WT-GFP, or SARA-F728A-GFP and immunostained to detect MAP2 (red channel) and Tau-1 (blue channel) epitopes. Briefly, neurons
were transfected after plating and fixed at three DIV for IF staining. (B–E) Quantification of neuronal polarity acquisition (%) (stage 2: multipolar neurons; stage 3:
polarized neurons and multiaxonic neurons) (B), number of axons per neuron (C), axonal length (D) and minor neurite length in 2 DIV neurons (MAP2-positive
neurites 2–3 times shorter than Tau-1 positive axon) (E). *p < 0.05, **p < 0.005, ***p < 0.001 vs control (white column), ns: non-significant, ANOVA, Dunnett’s
post-test (45 neurons were analyzed by condition). Scale bar: 20 µm. (F) Representative images of 3 DIV hippocampal neurons treated with TGFβ (2 ng/ml) or
SB431542 (10 µM) (TβRI inhibitor) compared with control condition and immunostained to detect Tau-1 epitope (blue). (G) Quantification of axonal length after TGFβ
(2 ng/ml) or SB431542 (10 µM) treatments in 3 DIV neurons. (H,I) Quantification of neuronal polarity acquisition (%) after either TGFβ (H) or SB431542 treatments (I)
in 3 DIV neurons (stage 2: multipolar neurons; stage 3: polarized neurons and multiaxonic neurons). *p < 0.05, **p < 0.005, ***p < 0.001 vs control, ns:
non-significant, ANOVA, Dunnett”s post-test (30 neurons were analyzed by condition). Arrows show axons in all images. Results represent the mean of three
independent cultures (n = 3). Scale bar: 20 µm
affecting cortical migration of neurons to the apical layers of the
cerebral cortex.
In summary, our work proposes that SARA is required
to down-regulate the TGFβ pathway during the early stages
of hippocampal and cortical development of neurons, most
likely by the local recruitment of PP1c/GADD34 complex
at EEs and dephosphorylation of TβRI. These findings
support the notion that TGFβ pathway requires a proper and
well-balanced modulation to promote neuronal development
and function.
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FIGURE 4 | Over-activation of the TGFβ pathway by SARA-F728A-GFP ectopic expression alters both polarity acquisition and cortical migration of neurons in vivo.
(A) Representative E18 coronal slices of brain cortices after in utero electroporation (IUE) of embryonic brains at E15, expressing pCAG-GFP, SARA-F728A-GFP, or
SARA-WT-GFP and inmunostained for DAPI (blue). Three days after IUE (E18), brains were fixed and sectioned for confocal imaging. (B) Magnifications of insets
shown in A (red squares). Neuronal morphologies and neurites developed during cortical migration are shown (red arrows: bipolar neurons; white arrows: multipolar
neurons). (C) Quantification of GFP positive cells by layer (%). (D) Quantification of main morphologies detected in each condition at the boundary of SVZ/IZ.
*p < 0.05 vs control, ANOVA, Dunnett’s post-test (1,500 neurons were analyzed by condition). Results represent the mean of three independent IUE experiments
(n = 3). Scale bar: 50 µm.
DISCUSSION
Modulation of the TGFβ Pathway by
SARA
Previous reports have shown that SARA interacts with TβRI
in non-neural models. Consistently, our results confirm this
hypothesis and represent the first evidence of their interaction
in developing hippocampal neurons. Moreover, our AP-FRET
analysis suggests that the interaction between SARA and
TβRI occurs locally at EEs, the place where transduction of
TGFβ signaling pathway occurs (Figure 1). These results are
consistent with previous studies carried out in cell lines, reporting
the interaction between SARA and TβRI using colocalization
and co-immunoprecipitation assays (Tsukazaki et al., 1998;
Miura et al., 2000; Itoh et al., 2002). Accordingly, SARA
presents three structural motifs for biochemical interaction with
proteins involved on the TGFβ pathway: (a) the SBD domain
(Smad-Binding-Domain), which allows interaction with the
transcriptional factors Smad2 and Smad3, (b) the PBD domain
(Phosphatase-Binding-Domain), which allows SARA interaction
with PP1c and, (c) the C-terminal domain, promoting docking
between SARA and TβRI (Tsukazaki et al., 1998; Wu et al.,
2000; Bennett and Alphey, 2002; Qin et al., 2002). In this
regard, the precise contribution of SARA to the regulation of
TGFβ pathway is a matter of debate. Whereas several reports
associate SARA exclusively with the activation of the pathway
(Wu et al., 2000; Qin et al., 2002), other reports, mainly done
in D. melanogaster and COS-7 cells, show the opposed effect.
Thus, the loss of function of SARA, by expressing the mutant
SARA-F678A, turn-off the pathway by the reduction of PP1c
recruitment to TβRI, leading to the hyperphosphorylation of the
receptor and, consequently, the inhibition of TGFβ signaling
(Bennett and Alphey, 2002; Shi et al., 2004). Accordingly,
our data show that either the blockade or knock-down of
SARA (by expressing SARA-F728A, the mammalian fly homolog
SARA-F678A mutant, or shRNAs, respectively) increased nuclear
translocation of Smad2/3. In contrast, gain of function of SARA,
achieved by the ectopic expression of SARA-WT, impaired
nuclear translocation of Smad2/3 (Figure 1). Collectively,
these results suggest that SARA works as an inhibitor of the
TGFβ pathway in basal conditions during the first stages of
neuronal polarization.
Moreover, the analysis by AP-FRET showed that neurons
expressing SARA-F278A had higher FRET efficiency with PP1c
than SARA-WT, which occurs locally at EEs. A similar result
was obtained with GADD34 (another member of the TGFβ
pathway inactivation complex) (Figure 2). In this regard, neither
SARA-WT nor SARA-F728A have reported binding domains
for GADD34. Therefore, we hypothesize two mechanistic
options. First, the F728A mutation could lead to PP1c-GADD34
mislocation. Second, F728A mutant lock the complex in a
non-active state, unable to meet and dephosphorylate TβRI.
Thus, our results suggest that SARA, in cooperation with
several molecular partners, modulates the inactivation of TGFβ
signaling in neurons. Also, considering our and previous data,
the regulation of TGFβ pathway by SARA seems to be context-
dependent and should be analyzed in each cell type, tissue, and
developmental stage.
Consequences of TGFβ Modulation by
SARA Over Early Neuronal Development
The mechanism described in this work has direct implications
for neuronal development. Neurons expressing SARA-F728A
have longer axons compared to their controls; and besides,
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these neurons displayed a multiaxonic phenotype (Figure 3 and
Supplementary Figure 1). This phenotype was increased by
adding TGFβ soluble or abolished when neurons were treated
with a specific TGFβ receptor inhibitor (Figure 3). Similar results
were obtained previously by our group, since the suppression
of SARA (either in knock-down or knock-out neurons) leads to
the formation of supernumerary axons, suggesting a direct effect
on polarity acquisition (Arias et al., 2015). Moreover, exogenous
TGFβ is able to drive axonal growth and differentiation, and over-
expression of the TβRI leads to multiaxonic neurons (Yi et al.,
2010). Therefore, our work extends the knowledge regarding
the regulation of TGFβ signaling, reporting a functional cross-
talk between SARA and TGFβ needed for axonal growth and
polarization of hippocampal neurons (Figure 5).
During corticogenesis, newborn neurons exhibit multipolar
morphologies with a symmetric arrangement of immature
neurites. However, cortical neurons replaced these neurites after
axon specification to develop a bipolar morphology able to
migrate toward the pial surface (Ehlers and Polleux, 2010;
Kawauchi, 2015). Then, when radial migration takes place,
most of the neurons located at SVZ-IZ layers exhibit a bipolar
morphology, which is required for proper cortical migration
(Kriegstein and Noctor, 2004; Hatanaka and Yamauchi, 2013;
Mestres et al., 2016; Wilson et al., 2020). Embryonic brains
expressing SARA-F728A presented a higher number of neurons
with bipolar phenotype, as well as an increase in the
number of neurons reaching the upper layers of the cortex,
suggesting an enhancement of cortical migration (Figure 4).
However, the impact on wiring and connectivity required to
be examined. Based on in vitro and in vivo studies, the
gain of function of TGFβ signaling, after blocking SARA,
alters the balance of polarity acquisition, evidenced by the
development of multiaxonic neurons, axonal overgrowth, and
improvements on cortical migration of neurons (Figure 5).
Considering our data, these phenotypes probably rely on TβRI
hyperphosphorylation and amplification of TGFβ signaling,
being consistent with ex vivo results of rat brains where
treatment with TGFβ1 accelerates the migration of newborn
neurons (Siegenthaler and Miller, 2004). Moreover, TGFβ1/2/3
promote neuritic growth of chicken DRG explants (Unsicker
et al., 1996); consistently, a similar effect was observed in axons
of rat hippocampal neurons, without affecting dendritogenesis
(Ishihara et al., 1994). In addition, inhibition of TGFβ signaling,
by reducing Smad4 levels during embryogenesis, is required for
the proper spatio-temporal development of granular progenitor
cells (Fernandes et al., 2012).
FIGURE 5 | SARA is a negative regulator of the TGFβ pathway during early neuronal development. Schematic representation of the working model. SARA basally
controls the deactivation of TβRI through the recruitment of the inhibitory complex PP1c/GADD34 in the endosomes of polarizing neurons. The loss of function of
SARA by the dominant-negative SARA-F728A mutant, overactivated the TGFβ pathway. This functionally impacts neuronal development, promoting axonal growth,
and cortical migration of neurons during brain development.
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The knock-down of SARA in vivo (by IUE) impairs cortical
development of mouse brains, reducing cortical migration of
neurons even in postnatal days. In this context, our group
previously showed an abnormal supply of the L1 cell adhesion
molecule to growing axons, with a strong delay in neuronal
development. Moreover, the suppression of SARA alters leading
process orientation and multipolar-bipolar transition through an
L1-dependent mechanism (Mestres et al., 2016). Conversely, the
expression of SARA-F728A, did not arrested neurons at the IZ
during the early stages of the neocortex development, suggesting
that the PP1c domain is not involved in the normal localization
of L1. The fact that the F728A mutation increases the number
of bipolar neurons, most likely due to increased phosphorylation
of TβRI suggest that different domains in SARA may control
different aspects of neuronal differentiation mediated by TGFβ
dependent and independent mechanisms. However, the control
of L1 expression by TGFβ has not been described yet, thus it
may be important in further studies to address whether TGFβ
and L1 functions are mechanistically connected. Nevertheless,
TGFβ1 is able to up-regulate the expression of cell-adhesion
molecules, like N-CAM, integrin α3, αv, and β1 (Siegenthaler
and Miller, 2004). In contrast, the physiological relevance of
suppressing SARA is not necessarily equivalent to its loss of
function (e.g., by SARA mutant expression), at least in the
context of TGFβ signaling pathway. In this regard, SARA knock-
down decreases its protein levels, while SARA-F728A mutant
preserves a non-functional PP1c domain, making both strategies
not exactly equivalent. Together, these results suggest that TGFβ
over-activation by blocking SARA alters polarization and cortical
migration in vivo.
Finally, the signaling of TGFβ controls a wide variety
of physiological and pathological processes, including neural
differentiation at embryonic development (Tomoda et al., 1996;
Unsicker et al., 1996; Yi et al., 2010), inflammatory and immune
response (Gorelik et al., 2002; Takimoto et al., 2010), axonal
regeneration after injury (Sulaiman, 2016; Carmichael et al.,
2017), and the progression of several pathologies, including
Alzheimer’s and Parkinson’s diseases (Vawter et al., 1996;
Zhang et al., 2016; Caraci et al., 2018), psychiatric disorders
(Benes et al., 2007; Sun et al., 2010), and carcinogenesis (Mao
et al., 2006; Benes et al., 2007; Sun et al., 2010; David and
Massague, 2018; Hachim et al., 2018; Chen et al., 2020),
among others. Although several reports have described in
detail the regulation of TGFβ pathway (Wrana et al., 1994;
Massague, 1998; Massague and Chen, 2000), our work stress
the action of non-canonical regulators like SARA, a protein
usually associated with endosomes and trafficking machinery.
Previous studies have described that the trafficking of SARA
endosomes plays a crucial role during the development of
D. melanogaster and D. rerio, determining the fate of neuronal
precursors during cell division (Loubery et al., 2014, 2017;
Derivery et al., 2015; Kressmann et al., 2015). In addition to
trafficking functions, these works suggest that SARA endosomes
are also related to the regulation of cell signaling, such as
the Notch/Delta pathway (Coumailleau et al., 2009; Loubery
et al., 2014; Kressmann et al., 2015). Overall, it seems that
SARA is required not only to carry out trafficking functions,
such as endosome segregation but also for proper modulation
of molecules and signaling pathways required for neuronal
development and growth.
In conclusion, the molecular mechanism described in this
work suggest that SARA is an endogenous negative regulator able
to fine-tune the TGFβ signaling pathway to achieve polarization
and axonal growth of neurons properly.
MATERIALS AND METHODS
Primary Culture of Hippocampal Neurons
From Rat Embryonic Brains
Cultures of embryonic hippocampal neurons were done
following the protocol of Kaech and Banker (2006). Briefly,
pregnant Wistar rats (E18.5) were sacrificed and embryos were
removed to isolate the hippocampus, followed by enzymatical
and mechanical digestion. Neurons were plated in multi-
well dishes containing glass coverslips previously treated
with 1 mg/ml of poly-L-lysine (Sigma-Aldrich, St. Louis,
Missouri, United States) using Dulbeco’s Modified Eagles
Medium (DMEM; Thermo Fisher Scientific, Massachusetts,
United States), supplemented with 10% horse serum (Gibco,
Thermo Fisher Scientific, Massachusetts, United States), for
1 h at 37◦C and 5% CO2. Then, plating medium was replaced
by Neurobasal supplemented with B27, Glutamax, Sodium
Pyruvate and antibiotics (Pen/Strep) (Thermo Fisher Scientific,
Massachusetts, United States). All of the experiments were
approved by the Bioethical Research Committee of INIMEC-
CONICET-UNC and conducted following the guidelines
of the manual for animal experimentation approved by
the institutional animal care committee (INIMEC-National
Research Council and Universidad Nacional de Córdoba,
Argentina), the National Department of Animal Care and
Health (SENASA-Argentina) and Approval to conduct
the study was granted by the Animal Care and Ethics
Committee (CICUAL) of INIMEC-CONICET-UNC (Resolution
numbers 006/2017A and 012/2017A). Efforts were made
to minimize animal suffering and to reduce the number of
animals used.
Transfection of cDNA Coding Vectors
Constructs pCAG-GFP, pRK5-SARA-WT-GFP, and pCAG-
shRNA-SARA were kindly provided by Dr. Ching-Hwa Sung
(Weill Cornell Medical College, United States). The target
sequence of the shSARA is: 5′-AGCTTAAAAGGGAGAAC
ATGATGAGTGCCTCCATGGAGGCACTCATCATGTTCTCC-
3′. This construction was designed and developed by Dr. Jen-Zen
Chuang (Chuang et al., 2007) and used in Mestres et al., 2016.
The shRNA sequence targets both SARA isoforms since it is
within the PBD domain. pRK5-SARA-F728A-GFP was designed
by our group from pRK5-SARA-WT-GFP using a Quick
Change Site-Directed Mutagenesis Kit (Stratagene, California,
United States) with the following primers: Forward: 5′-G
CAGAGGCGAGTTTGGGCTGCTGCTGATGGGATCTTGCC-
3′ and Reverse: 5′-GGCAAGATCCCATCAGCAGCCCAAAC
TCGCCTCTGC-3′. Then pRK5-SARA-F728A-GFP was
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amplified in DH5a cells and colonies (Amp-resistant) were
selected for DNA purification using a mini-purification kit
(Promega, Wisconsin, United States). Purified pRK5-SARA-
F728A-GFP was sequenced in Macrogen (Korea) to verify
correct site-directed mutation. Subsequently, the vector was
again amplified in DH5a cells and colonies were selected. Amp-
resistant bacteria were selected for DNA purification (Qiagen,
Hilden, Germany).
Neurons were plated in 10% HS MEM medium for
1 h, when the medium was replaced, were transiently
transfected with Lipofectamine 2000 (Life Technologies,
CA, United States), following manufacturer’s instructions.
Complexes containing pCAG-GFP, SARA-WT-GFP, SARA-
F728A-GFP, or shRNA-SARA plus Lipofectamine 2000
were resuspended in Optimem (Thermo Fisher Scientific,
Massachusetts, United States) and dissolved in Neurobasal
for transfection; after 2 h it was replaced by Neurobasal
supplemented with B27, Glutamax, Sodium Pyruvate
and antibiotics (Thermo Fisher Scientific, Massachusetts,
United States). Experiments were performed at 18, 48, or 72 h
after cDNA transfection.
Primary Antibodies
The following antibodies were used in this study: anti-
SARA [mouse, sc-133071; 1:200 for immunoblotting and
1:100 for immunofluorescence (IF)], anti-PP1c (mouse, sc-
7482; 1:50 for IF), anti-GADD34 (mouse, sc-373815; 1:50
for IF), anti-TβRI (mouse, sc-101574; 1:100 for IF) and
anti-Smad2/3 (mouse, sc-398844; 1:100 for IF); all these
antibodies were purchased from Santa Cruz Biotechnology
(Dallas, Texas, United States). The antibody anti-MAP2 (rabbit,
1:500) and anti-Tau-1 (mouse, 1:500) were from Merck
Millipore (Darmstadt, Germany). Antibody anti-pSamd2/3
(rabbit, s465/s467, E8F3R, 1:50 for IF) was from Cell Signaling
(Danvers, MA, United States) and anti-phospho TβRI (rabbit,
ser165, Lot: DY1241; 1:50 for IF) was acquired from Elabscience
(Houston, Texas, United Sates).
TGFβ and SB431542 Treatment
Neurons were also treated with TGFβ1 (Lot. 0713354 D1014
from Acris GmbH, Germany) [physiological concentration:
2 ng/ml, (Fogel-Petrovic et al., 2007)] or SB431542 (10 µM)
(DaCosta Byfield et al., 2004; Koo et al., 2015) (Lot. N◦
0504746-44, Cayman Chemical Company, Michigan,
United States); both TGFβ1 and SB431542 were added 18 h
after plating.
In utero Electroporation (IUE) and
Imaging Acquisition
IUE were done following previous reports (Niwa et al., 1991;
Saito and Nakatsuji, 2001). Briefly, pregnant E15.5 C57bl/6
mice were anesthetized with isoflurane/oxygen mix (4% for
induction and 2% for maintenance) during the whole surgery,
using Tramadol (5 mg/kg) as analgesia during the procedure.
Embryos were exposed out of the maternal belly for local
injection of pCAG-GFP, pCAG-GFP + SARA-WT-GFP or
pCAG-GFP + SARA-F728A-GFP into lateral ventricle of the
brain. Fast green FCF dye (Sigma-Aldrich, St. Louis, Missouri,
United States; catalog number F7252) was co-injected with
DNAs to visualize injections. Then, brains were electroporated
using a BTX electroporator (ECM 830 Square Wave Pulse
generator, Fisher scientific, MA, United States) (1V = 39 V;
pulses: 5; duration: 50 ms; intervals between pulses: 950 ms)
with Tweezers w/Variable Gap 2 Square Platinum Electrodes
(Nepagene, Japan, CUY647P2 × 2). At E18, embryos were
sacrificed to check GFP expression in control and SARA-
WT or SARA-F728A genetic contexts. Brains expressing GFP
were fixed and immersed into a 30% w/v sucrose solution
for 24 h, at 4◦C. Cerebral cortex of GFP-positive brains was
sliced into 50 µm cortical sections using a cryostat (Leica
CM 1850, Leica Biosystems, Illinois, United States). Before the
imaging, tissues were permeabilized with 0.3% v/v Triton x-
100-PBS solution, followed by DAPI staining (15 min at RT).
Samples were mounted in Mowiol solution (Sigma-Aldrich,
St. Louis, Missouri, United States) imaging in a Zeiss LSM-
800 confocal microscopy (Zeiss, Oberkochen, Germany). Images
were acquired with a 20× air objective. Several fields were
acquired (from the ventricular zone to the cortical plate). For
migration analysis, the embryonic neocortex was divided in 4
zones (from the bottom to the top): ventricular zone (VZ),
subventricular zone (SVZ), intermediate zone (IZ) and cortical




Neurons were cultured in p24 multi-wells (5 × 104 cells/well)
and transfected with cDNA–coding vectors as detailed before.
Immunofluorescence detections were done for TβRI, PP1c, or
GADD34. FRET efficiency measurements were performed as
described previously (Grzanka et al., 2014; Bignante et al.,
2018). De-quenching of the donor (GFP) after selective photo-
bleaching of the acceptor causes an increase in donor emission
(460–490 nm) that was quantified. For this, pre and post-
bleaching images of the donor and acceptor were obtained.
The measurement of FRET efficiency was carried out by
selecting the photo boiled region of the acceptor and measuring
FRET eff = 1-Pre-Donor/Post-Donor. ROIs were selected in
areas with endosome overexpression or randomized in the
control conditions.
Measurement of Smad2/3 Nuclear
Translocation
Transfected neurons were treated with TGFβ1 (2 ng/ml) at
18 h of culture for 0, 30, 60, and 120 min. Then, neurons
were fixed and immunostained to detect total Smad2/3 and
phospho-Smad2/3; DAPI was used to stain the nuclei. The ratio
[phospho-Smad2/3/t Smad2/3] was quantified in the nuclei in a
ROI defined by DAPI staining (Ranganathan et al., 2007). The
result was obtained from a Z projection of a stack of confocal
sections acquired by Zeiss LSM-800 confocal microscopy (Zeiss,
Oberkochen, Germany).
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Image Acquisition, Analysis, and
Statistics
Cells were visualized using either a spectral (Olympus
Fluoview 1000, Shinjuku City, Tokyo, Japan) or LSM-800
(Zeiss, Oberkochen, Germany) (Lasers: 488, 533, and 633;
resolution X = 1024; Y = 1024, and Z = 0.3–0.5 µm;
Objectives: 63×: Plan-Apochromat 63×/1.40 Oil DICM27
and 20×: Objective 20× LD Apochromat 20×/0.40, both
inverted confocal microscopes. Post-imaging analysis were
done using Fiji-ImageJ (NIH, United States) (Schindelin
et al., 2012). Results represent the mean ± SEM from of
at least three independent cultures (n = 3). The number
of neurons analyzed by each experiment are indicated in
the figure legends. Shapiro–Wilk normalcy test was used to
evaluate normal distribution of datasets. Student’s t-tests or
ANOVA were performed for parametric data. Mann–Whitney
or Kruskal–Wallis tests were used for non-parametric data using
GraphPad Prism 5.
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FIGURE S1 | Over-activation of the TGFβ pathway by SARA-F728A-GFP
generates multi-axonal neurons. (A) Representative images of cultured
hippocampal neurons transfected with SARA-F728A-GFP and immunostained to
detect MAP2 (red channel) and Tau-1 (blue channel) epitopes. Neurons were
transfected after plating and fixed at 3 DIV for IF staining. Arrows show axons in
the images. Results represent the mean of three independent cultures (n = 3).
Scale bar: 20 µm.
FIGURE S2 | Contribution of SARA to TGFβ-dependent axonal growth during
neuronal development. (A) Representative images of three DIV hippocampal
neurons transfected with GFP, SARA-WT-GFP, or SARA-F728A-GFP and treated
with TGFβ (2 ng/ml) or SB431542 (10 µM) (TβRI inhibitor). Results represent
different examples from three independent cultures (n = 3). Scale bar: 20 µm.
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